Evidence map›Paper›PMID 37277546›Full record

ArticleScientific reports2023

Value of [

Ewa Burchardt, Agnieszka Bos-Liedke, Kamila Serkowska, Paulina Cegla, Adam Piotrowski, Julian Malicki

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. [Diagnostics (Basel, Switzerland) · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ewa BurchardtDepartment of Radiotherapy and Oncological Gynecology, Greater Poland Cancer Center, 61-866, Poznan, Poland.
Agnieszka Bos-LiedkeDepartment of Biomedical Physics, Adam Mickiewicz University, 61-614, Poznan, Poland. agnbos@amu.edu.pl.
Kamila SerkowskaAsseco Poland S.A., 44-100, Gliwice, Poland.
Paulina CeglaDepartment of Nuclear Medicine, Greater Poland Cancer Center, 61-866, Poznan, Poland.
Adam PiotrowskiDepartment of Biomedical Physics, Adam Mickiewicz University, 61-614, Poznan, Poland.
Julian MalickiDepartment of Medical Physics, Greater Poland Cancer Center, 61-866, Poznan, Poland.
Adam Mickiewicz University in Poznań · PLGreater Poland Cancer Center · PLAsseco (Poland) · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first-order statistical (FOS) and second-order texture analysis on basis of Gray-Level Co-occurence Matrix (GLCM) were obtained to assess metabolic, volumetric, statistical and radiomic parameters of cervical cancer in response to chemotherapy, recurrence and age of patients. The homogeneous group of 83 patients with histologically confirmed IIIC1-IVB stage cervical cancer were analyzed, retrospectively. Before and after chemotherapy, the advancement of the disease and the effectiveness of the therapy, respectively, were established using [

Indexed as

Fluorodeoxyglucose F18Uterine Cervical NeoplasmsFemaleHumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesTumor BurdenFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID37277546
PMCPMC10241798
OpenAlexW4379468957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.